
Phathom Pharmaceuticals Inc (PHAT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -285.588 | -197.715 | -46.739 | -59.389 | -111.632 | -69.676 |
Return on Equity (%) | 200.311 | -225.113 | -61.137 | -108.009 | 14877.577 | 273.21 |
Return on Invested Capital (%) | 190.513 | -85.223 | -51.92 | -67.119 | -182.832 | -465.143 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -23405.279 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -29558.944 |
Book Value Per Share | -0.212 | 9.218 | 6.813 | 2.365 | -1.804 | -1.271 |
Earnings Per Share | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
Cash Per Share | 0.145 | 9.858 | 10.082 | 6.006 | 3.747 | 6.662 |
Working Capital Per Share | -0.212 | 10.185 | 8.271 | 5.493 | 3.238 | 6.264 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.009 |
EBIT Per Share | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
EBITDA Per Share | -0.213 | -10.317 | -4.526 | -4.716 | -4.768 | -3.521 |
Free Cash Flow Per Share | -0.213 | -9.297 | -4.5 | -4.722 | -4.758 | -3.503 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,05M | 24,73M | 28,52M | 30,51M | 41,47M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 41,47M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -3435.356 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -4333.264 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 378,81M |
Ratio cours/bénéfice | -1,93 |
Ratio prix/ventes | 569 |
Ratio prix/liquidités | 1,02 |
Ratio prix/valeur comptable | -5,35 |
Rendement de dividende | - |
Actions en circulation | 68,38M |
Volume moyen (1 semaine) | 953,24k |
Volume moyen (1 mois) | 1,03M |
Variation sur 52 semaines | -41,89% |
Plus haut sur 52 semaines | 19,675 |
Plus bas sur 52 semaines | 5,21 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales